92 related articles for article (PubMed ID: 21119597)
41. A novel chemical attack on Notch-mediated transcription by targeting the NACK ATPase.
Diluvio G; Kelley TT; Lahiry M; Alvarez-Trotta A; Kolb EM; Shersher E; Astudillo L; Kovall RA; Schürer SC; Capobianco AJ
Mol Ther Oncolytics; 2023 Mar; 28():307-320. PubMed ID: 36938545
[TBL] [Abstract][Full Text] [Related]
42. In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103.
Spriano F; Tarantelli C; Arribas AJ; Gaudio E; Cascione L; Aresu L; Rinaldi A; Zucca E; Rossi D; Stathis A; Murone M; Radtke F; Lehal R; Bertoni F
Br J Haematol; 2023 Mar; 200(5):669-672. PubMed ID: 36484636
[No Abstract] [Full Text] [Related]
43. Correction: LINC01152 upregulates MAML2 expression to modulate the progression of glioblastoma multiforme via Notch signaling pathway.
Wu J; Wang N; Yang Y; Jiang G; Mu Q; Zhan H; Li F
Cell Death Dis; 2021 Sep; 12(10):862. PubMed ID: 34556630
[No Abstract] [Full Text] [Related]
44. Notch targeting 2.0.
Aster JC
Blood; 2009 Jun; 113(24):6044-5. PubMed ID: 19520812
[No Abstract] [Full Text] [Related]
45. Comprehensive genomic features indicative for Notch responsiveness.
Giaimo BD; Friedrich T; Ferrante F; Bartkuhn M; Borggrefe T
Nucleic Acids Res; 2024 May; 52(9):5179-5194. PubMed ID: 38647081
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional reprogramming by mutated IRF4 in lymphoma.
Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
[TBL] [Abstract][Full Text] [Related]
47. The Expression of the Cancer-Associated lncRNA
Pensold D; Gehrmann J; Pitschelatow G; Walberg A; Braunsteffer K; Reichard J; Ravaei A; Linde J; Lampert A; Costa IG; Zimmer-Bensch G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572758
[TBL] [Abstract][Full Text] [Related]
48. A Dynamic Role of Mastermind-Like 1: A Journey Through the Main (Path)ways Between Development and Cancer.
Zema S; Pelullo M; Nardozza F; Felli MP; Screpanti I; Bellavia D
Front Cell Dev Biol; 2020; 8():613557. PubMed ID: 33425921
[TBL] [Abstract][Full Text] [Related]
49. Pan-Cancer Landscape Analysis Reveals Recurrent
Massoth LR; Hung YP; Dias-Santagata D; Onozato M; Shah N; Severson E; Duncan D; Gillespie BJ; Williams NF; Ross JS; Vergilio JA; Harkins SK; Glomski K; Nardi V; Zukerberg LR; Hasserjian RP; Louissaint A; Williams EA
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923872
[TBL] [Abstract][Full Text] [Related]
50. Advances in targeted therapy for malignant lymphoma.
Wang L; Qin W; Huo YJ; Li X; Shi Q; Rasko JEJ; Janin A; Zhao WL
Signal Transduct Target Ther; 2020 Mar; 5(1):15. PubMed ID: 32296035
[TBL] [Abstract][Full Text] [Related]
51. The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies.
Arruga F; Vaisitti T; Deaglio S
Front Oncol; 2018; 8():550. PubMed ID: 30534535
[TBL] [Abstract][Full Text] [Related]
52. WebHERV: A Web Server for the Computational Investigation of Gene Expression Associated With Endogenous Retrovirus-Like Sequences.
Kruse K; Nettling M; Wappler N; Emmer A; Kornhuber M; Staege MS; Grosse I
Front Microbiol; 2018; 9():2384. PubMed ID: 30455669
[TBL] [Abstract][Full Text] [Related]
53. B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.
Arima H; Nishikori M; Otsuka Y; Kishimoto W; Izumi K; Yasuda K; Yoshimoto T; Takaori-Kondo A
Blood Adv; 2018 Sep; 2(18):2282-2295. PubMed ID: 30213787
[TBL] [Abstract][Full Text] [Related]
54. Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.
Braune K; Volkmer I; Staege MS
PLoS One; 2017; 12(1):e0170694. PubMed ID: 28135309
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
56. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
57. Expression Patterns of Circular RNAs from Primary Kinase Transcripts in the Mammary Glands of Lactating Rats.
Zhang C; Wu H; Wang Y; Zhao Y; Fang X; Chen C; Chen H
J Breast Cancer; 2015 Sep; 18(3):235-41. PubMed ID: 26472973
[TBL] [Abstract][Full Text] [Related]
58. Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.
Wein F; Otto T; Lambertz P; Fandrey J; Hansmann ML; Küppers R
Haematologica; 2015 Oct; 100(10):1320-6. PubMed ID: 26160878
[TBL] [Abstract][Full Text] [Related]
59. miR-1322 Binding Sites in Paralogous and Orthologous Genes.
Niyazova R; Berillo O; Atambayeva S; Pyrkova A; Alybayeva A; Ivashchenko A
Biomed Res Int; 2015; 2015():962637. PubMed ID: 26114118
[TBL] [Abstract][Full Text] [Related]
60. The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role?
Kuksin CA; Minter LM
Front Oncol; 2015; 5():51. PubMed ID: 25759795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
